These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8086353)

  • 1. Chlorambucil for platinum-refractory ovarian cancer.
    Taylor AE; Gore ME
    Clin Oncol (R Coll Radiol); 1994; 6(3):177-8. PubMed ID: 8086353
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A reappraisal of the role of chlorambucil in patients with end stage ovarian cancer who have previously been treated with platinum regimens.
    McCully KS; Narayansingh GV; Cumming GP; Sarkar TK; Parkin DE
    Scott Med J; 2000 Apr; 45(2):51-3. PubMed ID: 10862439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Palliative benefit of external-beam radiation in the management of platinum refractory epithelial ovarian carcinoma.
    Gelblum D; Mychalczak B; Almadrones L; Spriggs D; Barakat R
    Gynecol Oncol; 1998 Apr; 69(1):36-41. PubMed ID: 9570996
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative evaluation of combined radiation-chlorambucil treatment of ovarian carcinomatosis.
    Miller SP; Brenner S; Horton J; Stolbach L; Shnider BI; Pocock S
    Cancer; 1975 Nov; 36(5):1625-30. PubMed ID: 811350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged intake of chlorambucil for ovarian cancer.
    Khalil AM; Khatib RA; Shamseddine AI; Sharara NH; Seoud MA
    Eur J Obstet Gynecol Reprod Biol; 1995 May; 60(1):85-6. PubMed ID: 7635238
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined cyclophosphamide, adriamycin and cis-platinum in advanced ovarian cancer resistant to chlorambucil and cis-platinum.
    Mann GJ; Malden LT; Solomon HJ; Tattersall MH
    Gynecol Oncol; 1985 Jun; 21(2):215-9. PubMed ID: 3886497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of treatment and prognosis of recurrent epithelial ovarian carcinoma].
    Yuan GW; Wu LY; Yao HW; Hou JL; Li XG; Liu LY
    Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):710-3. PubMed ID: 20021871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Routine Clinical Practice for Patients With Recurrent Ovarian Carcinoma: Results From the TROCADERO Study.
    Freyer G; Ray-Coquard I; Fischer D; Martín AG; Kielhorn A; Chia V; Nanayakkara N; Taylor A
    Int J Gynecol Cancer; 2016 Feb; 26(2):240-7. PubMed ID: 26745696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salvage chemotherapy in recurrent platinum-resistant or refractory epithelial ovarian cancer with Carboplatin and distearoylphosphatidylcholine pegylated liposomal Doxorubicin (lipo-dox®).
    Khemapech N; Oranratanaphan S; Termrungruanglert W; Lertkhachonsuk R; Vasurattana A
    Asian Pac J Cancer Prev; 2013; 14(3):2131-5. PubMed ID: 23679331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum-based chemotherapy of high-risk stage I epithelial ovarian cancer following comprehensive surgical staging.
    Rubin SC; Wong GY; Curtin JP; Barakat RR; Hakes TB; Hoskins WJ
    Obstet Gynecol; 1993 Jul; 82(1):143-7. PubMed ID: 8515915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant Chemotherapy Followed by Interval Debulking Surgery and the Risk of Platinum Resistance in Epithelial Ovarian Cancer.
    da Costa AA; Valadares CV; Baiocchi G; Mantoan H; Saito A; Sanches S; Guimarães AP; Achatz MI
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S971-8. PubMed ID: 26014155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Operation, external irradiation, radioactive isotopes, and chemotherapy in treatment of metastatic ovarian malignancies.
    Villasanta U; Bloedorn FG
    Am J Obstet Gynecol; 1968 Oct; 102(4):531-6. PubMed ID: 4176065
    [No Abstract]   [Full Text] [Related]  

  • 13. 5-Fluorouracil (5-FU) and leucovorin in platinum-refractory advanced stage ovarian carcinoma.
    Reed E; Jacob J; Ozols RF; Young RC; Allegra C
    Gynecol Oncol; 1992 Sep; 46(3):326-9. PubMed ID: 1526510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes of recurrent epithelial ovarian cancer: experience from a Thailand northern tertiary care center.
    Jansaka N; Suprasert P
    Asian Pac J Cancer Prev; 2014; 15(24):10837-40. PubMed ID: 25605186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-intense taxol: high response rate in patients with platinum-resistant recurrent ovarian cancer.
    Kohn EC; Sarosy G; Bicher A; Link C; Christian M; Steinberg SM; Rothenberg M; Adamo DO; Davis P; Ognibene FP
    J Natl Cancer Inst; 1994 Jan; 86(1):18-24. PubMed ID: 7505830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute leukemia following chlorambucil therapy of advanced ovarian and fallopian tube carcinoma.
    Morrison J; Yon JL
    Gynecol Oncol; 1978 Feb; 6(1):115-20. PubMed ID: 620948
    [No Abstract]   [Full Text] [Related]  

  • 17. Retrospective comparative study of irinotecan and pegylated liposomal doxorubicin for platinum-resistant or -refractory epithelial ovarian and primary peritoneal carcinoma.
    Ichikawa R; Torii Y; Oe S; Kawamura K; Kato R; Hasegawa K; Udagawa Y
    Arch Gynecol Obstet; 2014 Nov; 290(5):979-84. PubMed ID: 24798935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cisplatin, adriamycin and cyclophosphamide (PACe) combination chemotherapy in patients with ovarian carcinoma resistant to chlorambucil.
    Mead GM; Williams CJ; Whitehouse JM
    Cancer Chemother Pharmacol; 1985; 15(2):179-80. PubMed ID: 3839443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Recurrence risk factors of platinum-sensitive epithelial ovarian cancer].
    Yan XJ; Liang LZ; Zeng ZY; Liu JH; Yuan SH; Wei M
    Ai Zheng; 2005 Jun; 24(6):751-4. PubMed ID: 15946495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma.
    ten Bokkel Huinink W; Carmichael J; Armstrong D; Gordon A; Malfetano J
    Semin Oncol; 1997 Feb; 24(1 Suppl 5):S5-19-S5-25. PubMed ID: 9122738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.